Status and Future Directions for Balloon Pulmonary Angioplasty in Chronic Thromboembolic Pulmonary Disease With and Without Pulmonary Hypertension
Published: March 07, 2024
- Balloon pulmonary angioplasty continues to gain traction as a treatment option for patients with chronic thromboembolic pulmonary disease (CTEPH) with and without pulmonary hypertension.
- CTEPH centers are rapidly initiating balloon pulmonary angioplasty programs and there is a need for comprehensive, expert consensus and standardized approach to preprocedural planning and establishing criteria for evaluating procedural efficacy and safety.
- This statement summarizes the status of the procedure and provides a consensus opinion on the role of balloon pulmonary angioplasty in the overall care of patients with chronic thromboembolic pulmonary disease with and without pulmonary hypertension.
Balloon Pulmonary Angioplasty for patients with Chronic Thrombo-embolic Pulmonary Disease
Interventional Cardiologists Jay Giri from the University of Pennsylvania and Vikas Aggarwal from Michigan share insights on the novel therapy, Balloon Pulmonary Angioplasty, used to treat chronic thromboembolic pulmonary hypertension. They discuss various aspects of the procedure, including its origins, its application, patient candidacy and procedural risks. Both doctors emphasize on the importance of education, safe practices, and a comprehensive team approach while conducting this treatment, and note the improvements in complication rates and the potential for this therapy to expand to more centers.